Cohort Study: Effectiveness of homologous vs. heterologous booster doses for an inactivated SARS-CoV-2 vaccine.

Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study – The Lancet Global Health

Commentaries:

COVID-19 vaccine booster strategy: striving for best practice – The Lancet Global Health

Covid-19: Mix and match booster vaccination approach offers best protection, study reports – The BMJ

Commentary on Twitter

Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study https://t.co/0k7WlphoDV Heterologous booster provided ⬆️ protection than homologous one, especially when Coronavac vaccine had been used.

— Carlos del Rio (@CarlosdelRio7) April 25, 2022